Skip to main content

Loading market data...

NVS

Novartis AG

NYSE • United states

$153.93

+$0.29

(+0.19%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:00 GMT+0000

Management
Credibility
Score

Novartis AG (NVS)

Unavailable

Quotes may be delayed

$293.72B

Market Cap

1,019,095

Volume

Unavailable

P/E Ratio

3.11%

Div Yield

Novartis AG Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: LICHTSTRASSE 35, BASEL, V8
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

4 Feb 2026

Novartis AG securities registration filing

Novartis AG filed a registration or prospectus document concerning securities.

28 Oct 2025

Novartis AG tender offer filing

Novartis AG filed Schedule TO-T/A (amended third-party tender offer).

22 Oct 2025

Novartis AG tender offer filing

Novartis AG filed Schedule TO-T/A (amended third-party tender offer).

20 Oct 2025

Novartis AG tender offer filing

Novartis AG filed Schedule TO-T/A (amended third-party tender offer).

29 Sep 2025

Novartis AG tender offer filing

Novartis AG filed Schedule TO-T (third-party tender offer).

Capital Structure & Financial Position

Financial strength and liquidity analysis

Verified Capital Structure Unavailable

Balance-sheet, credit-rating, debt, and capital-activity data require sourced financial statement ingestion.

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Verified Financial Statements Unavailable

Verified financial statement data is not ingested for this stock yet.

Analyst Consensus

Buy

Target: $159.00

3.3% upside potential

📈

Strong Buy

Unavailable

👍

Buy

3

⏸️

Hold

3

📉

Sell

0

6 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 22 Oct 2026, 01:48 UTC Targets range 136.00–185.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

14

Jul 2020

NOVARTIS PHARMA AG

10% owner

Conversion

Unavailable per share

5,908,089 shares

30

Jun 2020

Novartis Bioventures Ltd

Conversion

Unavailable per share

1,056,258 shares

30

Jun 2020

Novartis Bioventures Ltd

Open-market purchase

$17.00 per share

125,000 shares

19

Jun 2020

Novartis Bioventures Ltd

Open-market sale

$8.25 per share

1,001,312 shares

18

Jun 2020

Novartis Bioventures Ltd

Open-market sale

$9.04 per share

900 shares

17

Jun 2020

Novartis Bioventures Ltd

10% owner

Open-market sale

$9.27 per share

4,622 shares

16

Jun 2020

Novartis Bioventures Ltd

10% owner

Open-market sale

$9.30 per share

8,600 shares

15

Jun 2020

Novartis Bioventures Ltd

10% owner

Open-market sale

$9.05 per share

6,164 shares

12

Jun 2020

Novartis Bioventures Ltd

10% owner

Open-market sale

$9.19 per share

1,500 shares

11

Jun 2020

Novartis Bioventures Ltd

10% owner

Open-market sale

$9.21 per share

7,200 shares

Top Shareholders

Fisher Asset Management, Llc

15,523,378 shares

11.794% change

6/30/2026

Morgan Stanley

8,726,827 shares

2.343% change

6/30/2026

Dimensional Fund Advisors Lp

8,117,586 shares

0.092% change

6/30/2026

Primecap Management Co/Ca/

6,592,124 shares

-12.887% change

6/30/2026

Loomis Sayles & Co L P

5,239,309 shares

-3.442% change

6/30/2026

Bank Of America Corp /De/

4,909,938 shares

-1.065% change

6/30/2026

Franklin Templeton Inc

3,251,281 shares

-4.653% change

6/30/2026

Blackrock, Inc.

3,047,988 shares

3.33% change

6/30/2026

Goldman Sachs Group Inc

2,980,168 shares

-54.332% change

6/30/2026

Northern Trust Corp

2,792,745 shares

0.234% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 22 Oct 2026, 01:48 UTC· 5 hours ago

Research coverage and investment tools

Novartis AG (NVS) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its last price was US$153.93 on 21 Oct 2026. That is 66% of the way from its 52-week low of US$121.57 to its 52-week high of US$170.46. It paid US$4.77 a share in dividends over the last 12 months, a dividend yield of 3.11%. The latest ex-dividend date on file is 11 Mar 2026. Its market capitalisation was US$293.72 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	7/21/2026	$2.41	$2.20	+9.6%
Mar 2026	4/28/2026	$1.99	$2.11	-5.7%
Dec 2025	2/4/2026	$2.03	$1.99	+2.0%
Sep 2025	10/28/2025	$2.25	$2.26	-0.4%

S-8 · 4 Feb 2026

Novartis AG securities registration filing (opens in a new tab)

Novartis AG filed a registration or prospectus document concerning securities.
SC TO-T/A · 28 Oct 2025 · Merger or acquisition Tender offer

Novartis AG tender offer filing (opens in a new tab)

Novartis AG filed Schedule TO-T/A (amended third-party tender offer).
SC TO-T/A · 22 Oct 2025 · Merger or acquisition Tender offer

Novartis AG tender offer filing (opens in a new tab)

Novartis AG filed Schedule TO-T/A (amended third-party tender offer).
SC TO-T/A · 20 Oct 2025 · Merger or acquisition Tender offer

Novartis AG tender offer filing (opens in a new tab)

Novartis AG filed Schedule TO-T/A (amended third-party tender offer).
SC TO-T · 29 Sep 2025 · Merger or acquisition Tender offer

Novartis AG tender offer filing (opens in a new tab)

Novartis AG filed Schedule TO-T (third-party tender offer).

Insider	Date	Transaction	Shares	Average price	Filing
NOVARTIS PHARMA AG 10% owner	14 Jul 2020	Conversion (C)	+5,908,089	—	Form 4 (opens in a new tab)
Novartis Bioventures Ltd	30 Jun 2020	Conversion (C)	+1,056,258	—	Form 4 (opens in a new tab)
Novartis Bioventures Ltd	30 Jun 2020	Open-market purchase (P)	+125,000	$17.00	Form 4 (opens in a new tab)
Novartis Bioventures Ltd	19 Jun 2020	Open-market sale (S)	−1,001,312	$8.25	Form 4 (opens in a new tab)
Novartis Bioventures Ltd	18 Jun 2020	Open-market sale (S)	−900	$9.04	Form 4 (opens in a new tab)
Novartis Bioventures Ltd 10% owner	17 Jun 2020	Open-market sale (S)	−4,622	$9.27	Form 4 (opens in a new tab)
Novartis Bioventures Ltd 10% owner	16 Jun 2020	Open-market sale (S)	−8,600	$9.30	Form 4 (opens in a new tab)
Novartis Bioventures Ltd 10% owner	15 Jun 2020	Open-market sale (S)	−6,164	$9.05	Form 4 (opens in a new tab)
Novartis Bioventures Ltd 10% owner	12 Jun 2020	Open-market sale (S)	−1,500	$9.19	Form 4 (opens in a new tab)
Novartis Bioventures Ltd 10% owner	11 Jun 2020	Open-market sale (S)	−7,200	$9.21	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Fisher Asset Management, Llc	6/30/2026	15,523,378	11.794%
Morgan Stanley	6/30/2026	8,726,827	2.343%
Dimensional Fund Advisors Lp	6/30/2026	8,117,586	0.092%
Primecap Management Co/Ca/	6/30/2026	6,592,124	-12.887%
Loomis Sayles & Co L P	6/30/2026	5,239,309	-3.442%
Bank Of America Corp /De/	6/30/2026	4,909,938	-1.065%
Franklin Templeton Inc	6/30/2026	3,251,281	-4.653%
Blackrock, Inc.	6/30/2026	3,047,988	3.33%
Goldman Sachs Group Inc	6/30/2026	2,980,168	-54.332%
Northern Trust Corp	6/30/2026	2,792,745	0.234%

Previous close: 153.64 USD
Day range: 152.93 – 154.12 USD
52-week range: 121.57 – 170.46 USD
Volume: 1,019,095
Market cap: $293.72B
Average volume: 1,763,685
Dividends (last 12 months): 4.77 USD
Dividend yield: 3.11%
Ex-dividend date: 11 Mar 2026
Shares outstanding: 1.91B
Beta (5Y monthly): 0.43

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:00 UTC· 11 hours ago

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:16 UTC· 58 minutes ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:16 UTC· 58 minutes ago

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for NVS yet

Financial statements
Balance sheet
Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.